Unlock stock picks and a broker-level newsfeed that powers Wall Street.

High Growth Tech Stocks To Watch In December 2024

In This Article:

As we approach the end of 2024, global markets have shown mixed signals with major U.S. stock indexes like the Nasdaq Composite experiencing moderate gains, although recent declines in consumer confidence and durable goods orders have raised concerns about economic stability. In this environment, high growth tech stocks are particularly intriguing due to their potential to capitalize on innovation and adaptability amidst fluctuating market conditions.

Top 10 High Growth Tech Companies

Name

Revenue Growth

Earnings Growth

Growth Rating

eWeLLLtd

26.41%

28.82%

★★★★★★

Waystream Holding

22.09%

113.25%

★★★★★★

Pharma Mar

25.43%

56.19%

★★★★★★

Sarepta Therapeutics

24.07%

43.17%

★★★★★★

CD Projekt

24.92%

27.00%

★★★★★★

TG Therapeutics

34.86%

56.98%

★★★★★★

Fine M-TecLTD

36.52%

131.08%

★★★★★★

Alkami Technology

21.99%

102.65%

★★★★★★

Elliptic Laboratories

70.09%

111.37%

★★★★★★

Travere Therapeutics

31.70%

72.51%

★★★★★★

Click here to see the full list of 1270 stocks from our High Growth Tech and AI Stocks screener.

Let's uncover some gems from our specialized screener.

Vitrolife

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Vitrolife AB (publ) specializes in providing products for assisted reproduction and has a market capitalization of approximately SEK29.81 billion.

Operations: Vitrolife generates revenue through three primary segments: Genetics (SEK1.23 billion), Consumables (SEK1.61 billion), and Technologies (SEK721 million).

Vitrolife, amidst executive shifts and active conference participation, reported a slight dip in third-quarter net income to SEK 116 million from SEK 122 million year-over-year, despite a revenue increase to SEK 867 million. This scenario underscores a resilience in sales growth but highlights challenges in profit retention. The company's commitment to innovation is evident as it navigates through leadership transitions and strategic presentations at major healthcare conferences. With an expected annual revenue growth of 8.2%, Vitrolife is outpacing the Swedish market's growth of 1.2%, yet it faces hurdles to achieving profitability within three years—a testament to its potential tempered by immediate financial realities.

OM:VITR Earnings and Revenue Growth as at Dec 2024
OM:VITR Earnings and Revenue Growth as at Dec 2024

Jonhon Optronic Technology

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Jonhon Optronic Technology Co., Ltd. focuses on the research and development of optical, electrical, and fluid connection technologies and equipment in China, with a market cap of CN¥84.34 billion.